Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
eli lilly
11
×
fda
11
×
life sciences
national blog main
11
×
biotech
clinical trials
boston blog main
boston top stories
indiana blog main
indiana top stories
national top stories
san francisco blog main
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
amgen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national
san diego blog main
san diego top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
drugs
abbvie
calcitonin gene-related peptide
cancer
chronic migraine
europe blog main
investing
migraine research foundation
What
drug
11
×
fda
approval
new
won
medicines
migraine
class
companies
eli
lilly
approved
bio
biotech
cancer
decades
developed
pain
research
roundup
starts
treatment
acute
addresses
administration
alkermes
alzheimer’s
amgen
angry
announced
annual
anti
antipsychotic
arguments
assessed
attention
benefited
benefits
bid
big
Language
unset
Current search:
fda
×
drug
×
" national blog main "
×
" eli lilly "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines